急性呼吸不全症候群：治療薬のグローバル治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Acute Respiratory Distress Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Respiratory Distress Syndrome to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Respiratory Distress Syndrome to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Respiratory Distress Syndrome 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Acute Respiratory Distress Syndrome Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Altor BioScience Corporation 35
Clinical Trial Overview of Altor BioScience Corporation 35
Therametrics holding AG 36
Clinical Trial Overview of Therametrics holding AG 36
Faron Pharmaceuticals Oy 37
Clinical Trial Overview of Faron Pharmaceuticals Oy 37
Mallinckrodt plc 38
Clinical Trial Overview of Mallinckrodt plc 38
Discovery Laboratories, Inc. 39
Clinical Trial Overview of Discovery Laboratories, Inc. 39
Debiopharm International S.A. 40
Clinical Trial Overview of Debiopharm International S.A. 40
Chiesi Farmaceutici SpA 41
Clinical Trial Overview of Chiesi Farmaceutici SpA 41
B. Braun Melsungen AG 42
Clinical Trial Overview of B. Braun Melsungen AG 42
APEIRON Biologics AG 43
Clinical Trial Overview of APEIRON Biologics AG 43
Clinical Trial Overview of Top Institutes / Government 44
National Heart, Lung, and Blood Institute 44
Clinical Trial Overview of National Heart, Lung, and Blood Institute 44
Policlinico Hospital 45
Clinical Trial Overview of Policlinico Hospital 45
University Hospital of Clermont-Ferrand 46
Clinical Trial Overview of University Hospital of Clermont-Ferrand 46
National Taiwan University Hospital 47
Clinical Trial Overview of National Taiwan University Hospital 47
Southeast University 48
Clinical Trial Overview of Southeast University 48
University of Oklahoma 49
Clinical Trial Overview of University of Oklahoma 49
Medical University of Vienna 50
Clinical Trial Overview of Medical University of Vienna 50
Assistance Publique Hopitaux De Marseille 51
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 51
Mayo Clinic 52
Clinical Trial Overview of Mayo Clinic 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Five Key Clinical Profiles 54
Appendix 78
Abbreviations 78
Definitions 78
Research Methodology 79
Secondary Research 79
About GlobalData 80
Contact Us 80
Disclaimer 80
Source 80